Why Catalyst Pharmaceuticals Shares Are Moving
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading higher by 9.66% to $15.72 Thursday morning after the company reported better-than-expected fourth-quarter results.
REE Automotive Q4 Cash And Equivalents $154M
As of December 31, 2022, the Company had $154 million of liquidity, comprised of cash, cash equivalents and short term investments, and no debt. The Company anticipates it has sufficient liquidity to achieve initial
Honest Co Q4 EPS $(0.14) Misses $(0.05) Estimate, Sales $81.86M Beat $80.37M Estimate
Honest Co (NASDAQ:HNST) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.05) by 180 percent. This is a 40 percent decrease over losses of $(0.10) per share from the same
VEON Q4 Sales $940.00M Down From $2.05B YoY
VEON (NASDAQ:VEON) reported $940.00 million in sales this quarter. This is a 54.19 percent decrease over sales of $2.05 billion the same period last year.
Fear & Greed Index Moves To ‘Extreme Fear’ Zone As Dow Dips Over 250 Points
The CNN Money Fear and Greed index moved to the "Extreme Fear" zone on Wednesday.
Fortuna Silver Mines Q4 EPS $0.02, Inline, Sales $164.70M Beat $160.70M Estimate
Fortuna Silver Mines (NYSE:FSM) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 77.78 percent decrease over earnings of $0.09 per share from the same period last year.
JOYY Q4 EPS $0.65 Beats $0.24 Estimate, Sales $586.73M Miss $601.65M Estimate
JOYY (NASDAQ:YY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.24 by 170.83 percent. This is a 43.48 percent decrease over earnings of $1.15 per share from the same period
Liminal Biosciences Q4 EPS $(1.72) Up From $(2.90) YoY, Sales $179.43K Down From $238.00K YoY
Liminal Biosciences (NASDAQ:LMNL) reported quarterly losses of $(1.72) per share. This is a 40.69 percent increase over losses of $(2.90) per share from the same period last year. The company reported $179.43 thousand
Steel Connect Q2 EPS $(0.02) Up From $(0.39) YoY, Sales $50.80M
Steel Connect (NASDAQ:STCN) reported quarterly losses of $(0.02) per share. This is a 94.87 percent increase over losses of $(0.39) per share from the same period last year. The company reported $50.80 million in sales
Liminal Biosciences Q4 2022 Net Loss C$(4.2M)
Liminal Biosciences (NASDAQ:LMNL) will report on Q4 2022.